Allele Symbol Allele Name Allele ID |
Fkbpltm1.1(KOMP)Wtsi targeted mutation 1.1, Wellcome Trust Sanger Institute MGI:5558157 |
||||||||||||||||||||
Summary |
4 genotypes
|
|
|
Data Sources
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
|
|
Data Sources
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
IMPC - TCP
|
IMPC - TCP
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• heterozygous intercrosses fail to yield any homozygotes, with embryonic lethality occurring before E8.5
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• following intradermal implantation of Lewis lung carcinoma (LLC) tumors, heterozygotes show an increase in CD31-stained blood vessels with the endothelium appearing thicker and less organized than in similarly-treated wild-type controls, indicating enhanced tumor angiogenesis
|
• in an ex vivo aortic ring assay, heterozygous mutant aortae show an enhanced pattern of sprouting with a significant increase in average vessel length relative to wild-type aortae
|
• in an ex vivo aortic ring assay, heterozygous mutant aortae show enhanced sprouting of vessels relative to wild-type aortae
• in an in vivo sponge assay, bFGF-treated polyether sponges implanted in mutant mice show a significantly higher number (15% to 20%) of endomucin-stained vessels relative to wild-type controls
|
• following intradermal implantation of Lewis lung carcinoma (LLC) tumors, heterozygotes show an increase in CD31-stained blood vessels with the endothelium appearing thicker and less organized than in similarly-treated wild-type controls, indicating enhanced tumor angiogenesis
|
• following intradermal implantation of LLC tumors, LLC cells grown on the rear dorsum of heterozygous mutant mice show an increased growth rate relative to those in similarly-treated wild-type controls
|
• following intradermal implantation of LLC tumors, heterozygotes show a significantly shorter survival (defined as time to reach >600 mm3 in tumor volume) than similarly-treated wild-type controls
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 11/12/2024 MGI 6.24 |
|
|